ArticleBMC microbiology2025
Transcription factor with ambivalent role - Ralstonia eutropha's PhaR is a repressor of the phasin-gene phaP1 and an activator of phaP3.
Article in BMC microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Polyhydroxyalkanoates (PHAs) serve as intracellular carbon and energy storage compounds in many prokaryotes. They accumulate in granules composed of a hydrophobic polymer core surrounded by a surface layer of proteins that regulate granule formation, stability, and degradation. Among these, the most abundant are low-molecular-weight, amphiphilic proteins known as phasins. In Ralstonia eutropha (Cupriavidus necator), one of the best-studied model organisms for PHA biosynthesis, the phasin PhaP1 controls the surface-to-volume ratio of the granule. Under non-accumulating conditions, the transcriptional repressor PhaR negatively regulates phaP1 expression. A similar PhaR-mediated repression has also been proposed for another phasin gene, phaP3, though direct evidence has so far been lacking. In this study, the phaP3 transcription start site was determined and three putative PhaR binding sites upstream and within the phaP3 gene identified. Electrophoretic mobility shift assays confirmed PhaR binding to all three sites. Strikingly, β-galactosidase reporter-gene assays revealed that, unlike its repressive effect on phaP1, PhaR activates phaP3 expression. Our findings provide the first direct evidence of the dual regulatory role of PhaR in R. eutropha, functioning as a repressor and activator of different phasin encoding genes. This suggests distinct physiological roles for PhaP1 and PhaP3 in PHA granule formation and turnover, further underscoring the complexity of the regulation of PHA metabolism.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.